140 related articles for article (PubMed ID: 32074321)
1. Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management.
Eisenstein TK; Chen X; Inan S; Meissler JJ; Tallarida CS; Geller EB; Rawls SM; Cowan A; Adler MW
Mil Med; 2020 Jan; 185(Suppl 1):130-135. PubMed ID: 32074321
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression.
Inan S; Chen X; Eisenstein EM; Meissler JJ; Geller EB; Tallarida C; Watson M; Doura M; Barrett JE; Cowan A; Rawls SM; Adler MW; Eisenstein TK
Life Sci; 2021 Nov; 285():120014. PubMed ID: 34619167
[TBL] [Abstract][Full Text] [Related]
3. Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats.
Inan S; Eisenstein TK; Watson MN; Doura M; Meissler JJ; Tallarida CS; Chen X; Geller EB; Rawls SM; Cowan A; Adler MW
J Pharmacol Exp Ther; 2018 Dec; 367(3):433-441. PubMed ID: 30249618
[TBL] [Abstract][Full Text] [Related]
4. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats.
Chen X; Geller EB; Rogers TJ; Adler MW
Drug Alcohol Depend; 2007 Apr; 88(1):36-41. PubMed ID: 17049756
[TBL] [Abstract][Full Text] [Related]
5. The effect of gp120 on morphine's antinociceptive and neurophysiological actions.
Chen X; Kirby LG; Palma J; Benamar K; Geller EB; Eisenstein TK; Adler MW
Brain Behav Immun; 2011 Oct; 25(7):1434-43. PubMed ID: 21569838
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats.
Inan S; Watson MN; Doura M; Tallarida CS; Meissler JJ; Chen X; Geller EB; Cowan A; Rawls SM; Eisenstein TK; Adler MW
Br J Anaesth; 2019 Jun; 122(6):e213-e215. PubMed ID: 30916010
[No Abstract] [Full Text] [Related]
7. Evaluation of Analgesia, Tolerance, and the Mechanism of Action of Morphine-6-O-Sulfate Across Multiple Pain Modalities in Sprague-Dawley Rats.
Yadlapalli JSK; Dogra N; Walbaum AW; Wessinger WD; Prather PL; Crooks PA; Dobretsov M
Anesth Analg; 2017 Sep; 125(3):1021-1031. PubMed ID: 28489639
[TBL] [Abstract][Full Text] [Related]
8. Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats.
Bongiovanni AR; Zhao P; Inan S; Wiah S; Shekarabi A; Farkas DJ; Watson MN; Wimmer ME; Ruff MR; Rawls SM
Drug Alcohol Depend; 2022 Sep; 238():109556. PubMed ID: 35843139
[TBL] [Abstract][Full Text] [Related]
9. CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.
Gonek M; McLane VD; Stevens DL; Lippold K; Akbarali HI; Knapp PE; Dewey WL; Hauser KF; Paris JJ
Brain Behav Immun; 2018 Mar; 69():124-138. PubMed ID: 29146238
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents.
Kopruszinski CM; Swiokla J; Lee YS; Navratilova E; VanderVeen L; Yang M; Liu Y; Miyazaki T; Schmidt WK; Zalevsky J; Porreca F
Cell Mol Neurobiol; 2021 Jul; 41(5):949-960. PubMed ID: 32107752
[TBL] [Abstract][Full Text] [Related]
11. Differential responses to morphine-induced analgesia in the tail-flick test.
Cecchi M; Capriles N; Watson SJ; Akil H
Behav Brain Res; 2008 Dec; 194(2):146-51. PubMed ID: 18656501
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
14. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103.
Ruff MR; Inan S; Shi XQ; Meissler JJ; Adler MW; Eisenstein TK; Zhang J
Life Sci; 2022 Oct; 306():120788. PubMed ID: 35817166
[TBL] [Abstract][Full Text] [Related]
16. Interaction between morphine and norketamine enantiomers in rodent models of nociception.
Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
Pharmacol Biochem Behav; 2008 Oct; 90(4):769-77. PubMed ID: 18582492
[TBL] [Abstract][Full Text] [Related]
17. Continuous local bupivacaine wound infusion with neuraxial morphine reduces opioid consumption after cesarean delivery.
Zaretsky M; Wood C; Nivens T; McLaughlin G; Zuk J; Pan Z; Chow F
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3895-3902. PubMed ID: 29848107
[No Abstract] [Full Text] [Related]
18. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function.
Schramm CL; Honda CN
Pain; 2010 Dec; 151(3):763-770. PubMed ID: 20970925
[TBL] [Abstract][Full Text] [Related]
20. Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures.
Minervini V; Lu HY; Padarti J; Osteicoechea DC; France CP
Psychopharmacology (Berl); 2018 Aug; 235(8):2245-2256. PubMed ID: 29785554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
